ProTransit Nanotherapy Overview
- Founded
-
2013
- Status
-
Private
- Employees
-
2
- Latest Deal Type
-
Series A
- (Cancelled)
- Latest Deal Amount
-
$500K
- Investors
-
5
ProTransit Nanotherapy General Information
Description
Developer of a proprietary sustained-release nanoparticle delivery system designed to treat conditions with a variety of active ingredients. The company's system contains antioxidant enzymes, where the product helps reduce photoaging caused by free radicals following sun exposure with other topical applications including active ingredients for hair loss and plaque psoriasis, enabling doctors to utilize under-development nanoparticles for the treatment of traumatic brain injury, hypertension, and prevention of skin damage from radiotherapy.
Contact Information
Website
www.protransitnanotherapy.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Primary Office
- 16514 L Street
- Omaha, NE 68144
- United States
+1 (608) 000-0000
ProTransit Nanotherapy Timeline
ProTransit Nanotherapy Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series A) | $500K | 000.00 | Cancelled | Clinical Trials - Phase 1 | ||
| 5. Grant | 01-Jun-2021 | 00000 | 00000 | Completed | Clinical Trials - Phase 1 | |
| 4. Grant | 30-Sep-2020 | 00000 | 00000 | Completed | Pre-Clinical Trials | |
| 3. Grant | 15-Aug-2018 | 00000 | 00000 | Completed | Pre-Clinical Trials | |
| 2. Grant | 08-Mar-2017 | $1.7M | $250K | Completed | Pre-Clinical Trials | |
| 1. Early Stage VC (Series A) | 21-Nov-2014 | $250K | $250K | Completed | Pre-Clinical Trials |
ProTransit Nanotherapy Patents
ProTransit Nanotherapy Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-2996126-A1 | Compositions and methods for the treatment of photoaging and other skin conditions | Active | 25-Aug-2014 | 0000000000 | |
| CA-2996126-C | Compositions and methods for the treatment of photoaging and other skin conditions | Active | 25-Aug-2014 | 0000000000 | |
| US-20170281735-A1 | Compositions and methods for the treatment of photoaging and other conditions | Active | 25-Aug-2014 | 0000000000 | |
| US-10517934-B2 | Compositions and methods for the treatment of photoaging and other conditions | Active | 25-Aug-2014 | A61K38/446 |
ProTransit Nanotherapy Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Gary Madsen Ph.D | Co-Founder, President & Chief Executive Officer | ||
| Vinod Labhasetwar Ph.D | Co-Founder & Advisor |
ProTransit Nanotherapy Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
ProTransit Nanotherapy Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Small Business Innovation Research and Small Business Technology Transfer Programs | Government | 000 0000 | 000000 0 | ||
| National Institutes of Health | Government | 000 0000 | 000000 0 | ||
| United States Department of Defense | Government | 000 0000 | 000000 0 | ||
| Artesian Beauty | Corporation | Minority | 000 0000 | 000000 0 | |
| Invest Nebraska | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |